Yahoo! Finance Canada report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Why DLB Stock slipped -1.46% Today — RQD Quant Desk Flash
Dolby Laboratories (DLB) earns a Roarable Rating of B+ (Buy) with 79/100 RQD Confidence. High-quality cash engine (88% profit margin, 10% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Dolby Laboratories (NYSE: DLB) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 79/100 at a spot price of $61.99 (-1.46% 1D, market cap $5.81B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 485 tracked Industrials issuers, DLB ranks #5 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DLB compare to IDCC and APPS in the Industrials sector?
▼
Within the Industrials sector (Multi-Sector Companies), DLB carries a Roarable B+ (79/100 RQD), trailing P/E of 23.1x, gross margin of 88.1%, and ROIC of 9.5%. By comparison, IDCC (InterDigital Inc.) holds a B grade (75/100 RQD, P/E 21.2x, ROIC 52.8%, cap $8.02B) and APPS (Digital Turbine Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC 5.3%, cap $1.08B). Among the 5-stock peer group, ACTG leads on earnings multiple (17.7x) while IDCC leads on capital efficiency (52.8% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DLB?
▼
Per DLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-26, CIK 0001308547), Dolby Laboratories generated $1.35B in revenue (+5.9% YoY), $255.0M in net income, and $435.9M in free cash flow against $3.19B in total assets and $265.2M in total debt. Key quantitative strengths: Strong cash generator (88% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 8.20 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
SEC XBRL FY 2025 (10-K): 32.3% FCF Margin ($435.9M FCF) & 88.1% Gross Margin
Put hedging (50% put share) caps near-term gamma upside (-6 pts vs max)
⚔️ Adversarial Opposing Case: Why the DLB Bull Thesis Could Fail
Even with a 79/100 (B+) score, DLB faces multiple-compression risk if 23.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 85.6% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($60.59) or 200D SMA ($59.28) invalidates the momentum regime and cuts Target Base ($67.85) toward Bear Floor ($50.83).
Why DLB Stock slipped -1.46% Today — RQD Quant Desk Flash
Dolby Laboratories (DLB) slipped -1.46% to $61.99, trading at 63% of its 52-week range ($48.26 – $69.95). High-quality cash engine (88% profit margin, 10% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 63% of its 52-week range ($48.26 – $69.95) with RSI-14 at 54 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±5.2% around $61.99 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B+ (Buy) backed by 88.1% gross margin and $435.9M annual free cash flow.
Seeking Alpha report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (DLB Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
DLB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DLB today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DLB. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DLB)
1. Head-to-Head Industrials Peer Comparison (DLB vs. IDCC, APPS, ACTG, JYNT)
Industry: Multi-Sector Companies (11 Tracked Issuers)Across 485 tracked Industrials securities in the Roarable RQD universe, Dolby Laboratories (DLB) ranks #5 by composite RQD confidence (79/100, grade B+) and #129 by equity capitalization ($5.81B). Within this direct 5-issuer industry benchmark cohort, ACTG leads on earnings valuation at 17.7x trailing P/E, while IDCC leads on capital efficiency and profitability with 52.8% ROIC and — gross margin. DLB currently leads its immediate peer cohort in composite quantitative strength at 79/100 (B+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DLB
ACTIVE
Dolby Laboratories | B+ | 79/100 | 23.1x | 88.1% | 9.5% | -1.46% | $5.81B | Benchmark Subject |
| IDCC InterDigital Inc. | B | 75/100 | 21.2x | — | 52.8% | -6.79% | $8.02B | /idcc-vs-dlb → |
| APPS Digital Turbine Inc. | D | 46/100 | — | 56.9% | 5.3% | -16.08% | $1.08B | /apps-vs-dlb → |
| ACTG Acacia Research Corporation (Acacia Tech) | D+ | 55/100 | 17.7x | 29.6% | 2.1% | -2.48% | $422.6M | /actg-vs-dlb → |
| JYNT The Joint Corp. | D- | 35/100 | 35.8x | — | -13.9% | -4.48% | $99.4M | /jynt-vs-dlb → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-09-26 • CIK 0001308547In its most recent audited fiscal period (FY2025, filed 2025-09-26), Dolby Laboratories (DLB) reported GAAP revenue of $1.35B (+5.9% vs. FY2024 revenue of $1.27B , and +3.8% cumulative change since FY2023) , GAAP net income of $255.0M, operating cash flow of $472.2M, and free cash flow of $435.9M (+46.6% YoY). On the balance sheet, DLB closed FY2025 with $3.19B in total assets against $265.2M in total debt (Altman Z-Score: 8.20, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-09-26 | $1.35B | $255.0M | $472.2M | $435.9M | $3.19B | $265.2M |
| FY2024 (FY) | 2024-09-27 | $1.27B | $261.8M | $327.3M | $297.2M | $3.16B | $288.7M |
| FY2023 (FY) | 2023-09-29 | $1.30B | $200.7M | $367.1M | $308.6M | $3.24B | $758.4M |
3. DLB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Dolby Laboratories (NYSE: DLB) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 79/100 at a spot price of $61.99 (-1.46% 1D, market cap $5.81B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 485 tracked Industrials issuers, DLB ranks #5 in composite RQD confidence.
How does DLB compare to IDCC and APPS in the Industrials sector?
Within the Industrials sector (Multi-Sector Companies), DLB carries a Roarable B+ (79/100 RQD), trailing P/E of 23.1x, gross margin of 88.1%, and ROIC of 9.5%. By comparison, IDCC (InterDigital Inc.) holds a B grade (75/100 RQD, P/E 21.2x, ROIC 52.8%, cap $8.02B) and APPS (Digital Turbine Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC 5.3%, cap $1.08B). Among the 5-stock peer group, ACTG leads on earnings multiple (17.7x) while IDCC leads on capital efficiency (52.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DLB?
Per DLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-26, CIK 0001308547), Dolby Laboratories generated $1.35B in revenue (+5.9% YoY), $255.0M in net income, and $435.9M in free cash flow against $3.19B in total assets and $265.2M in total debt. Key quantitative strengths: Strong cash generator (88% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DLB trading relative to its 50-day, 200-day, and 52-week technical levels?
DLB last traded at $61.99 (-1.46% on volume of 688,821 shares), positioning the stock +2.31% above its 50-day simple moving average ($60.59) and +4.57% above its 200-day simple moving average ($59.28). Across its 52-week range of $48.26 to $69.95, DLB sits at the 63.3% percentile with a 14-day RSI of 54.0 (NEUTRAL RANGE) and an implied next-earnings move of ±5.2% ($58.77 to $65.21).
DLB Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is DLB stock moving today?
Why DLB Stock slipped -1.46% Today — RQD Quant Desk Flash. High-quality cash engine (88% profit margin, 10% return on capital) with steady institutional support.
DLB — Dolby Laboratories: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, DLB scores 79 out of 100, a letter grade of B+, with the verdict "Roarable Buy — Very Good Cash & Smart-Money Inflow." The five pillars are:
- Fundamental Cash Engine: 16 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 9.5% and an FCF yield of 7.4%. For a prospective investor, this suggests the business converts capital into cash at a reasonable rate, with the FCF yield indicating how much cash the business generates relative to its market value.
- Whale 13F Flow: 14 / 20. Per the Roarable RQD rating, this pillar captures institutional accumulation and options positioning. The moderate score implies institutional interest is present but not the strongest component of the rating.
- Insider Conviction: 16 / 20. Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The score indicates a relatively supportive insider-flow signal, though the underlying trade-level detail is not included in the source data.
- Macro Regime Fit: 15 / 20. Per the Roarable RQD rating, this pillar reflects a beta of 1 and sector sensitivity. A beta of 1 implies the stock has historically moved in line with the broader market, so it is neither a defensive nor an aggressive market-sensitivity profile in this framework.
- Forensic Balance Sheet: 18 / 20. Per the Roarable RQD rating, this is the strongest pillar, citing an Altman Z of 8.2, a Piotroski F of 8/9, and a Debt/Equity of 0.1. For a prospective investor, the balance-sheet metrics point to low leverage and strong financial health by these measures.
Investor implications: the upside drivers in this framework are the cash generation, low leverage, and insider-flow signal. The valuation tradeoff is that the P/E (TTM) of 23.1 and EV/EBITDA of 18.6 are not low on their face, so the rating does not imply the stock is cheap on earnings multiples. Weaker pillars (Whale 13F Flow and Macro Regime Fit) indicate that institutional and macro support are more moderate. The rating is an analytical framework output, not a recommendation.
Snapshot
Business
Per the Profile section, Dolby Laboratories (DLB) is a NYSE-listed company in the Industrials sector, Multi-Sector Companies industry, with a market capitalization of $5.9B. The source data does not describe its products, customers, or revenue model. Per the market data, gross margin is 88.1%, operating margin is 19.6%, and net margin is 18.9%.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $1349.1M | $265.0M | $255.0M | N/A | $435.9M | $643.8M | $265.2M |
| FY 2024 | $1273.7M | $258.3M | $261.8M | N/A | $297.2M | $520.8M | $288.7M |
| FY 2023 | $1299.7M | $215.8M | $200.7M | N/A | $308.6M | N/A | $758.4M |
Per the SEC financials, revenue rose from $1273.7M in FY 2024 to $1349.1M in FY 2025, and operating income rose from $258.3M to $265.0M, while net income declined from $261.8M to $255.0M. Per the market data, operating margin is 19.6%, net margin is 18.9%, and ROIC is 9.5%. Per the Roarable RQD rating, the Altman Z-Score is 8.2 and the Piotroski F-Score is 8/9, and Debt/Equity is 0.1. Debt declined from $758.4M in FY 2023 to $265.2M in FY 2025.
Recent Catalysts & News Wire Analysis
- Earnings date (Stock Titan, MARKET WIRE): Q4 and full-year results are to be released after trading Nov. 17, with the call starting at 2 p.m. PT.
- Seeking Alpha (GREEN, CATALYST): Headline characterizes the company as having weak growth but a valuation described as too cheap.
- Simply Wall St (YELLOW, MARKET WIRE): Headline references a 32% slide and asks whether the stock is reasonably priced.
- Yahoo Finance (RED, RISK WATCH): Headline frames the company as risky, citing three reasons.
- MarketBeat (YELLOW, MARKET WIRE): Reports a sale of DLB stock by Robeco Institutional Asset Management B.V.
- Yahoo! Finance Canada (YELLOW, MARKET WIRE): General market and institutional positioning report.
The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals.
Open Questions
- What are the specific products, customers, and revenue drivers behind the reported revenue figures?
- What caused net income to decline in FY 2025 despite higher revenue and operating income?
- What are the specific insider and institutional trades underlying the Insider Conviction and Whale 13F Flow scores?
- What is the source of the "32% slide" referenced in news coverage, and how does it reconcile with the 52-week range?
- What are the EPS figures for each reported fiscal year, since the source data lists them as N/A?
DLB Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Dolby Laboratories (DLB) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo! Finance Canada report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Dolby Laboratories (DLB) market action, institutional positioning, and fundamental catalysts.
DLB Bull vs. Bear Conversation Board — What's Your Call at $61.99?
🔥 Official Bull vs. Bear Debate: Is DLB (B+ • RQD 79/100) a Buy at $62.91?
Welcome to the DLB (Dolby Laboratories) Roar Pit. Current RQD Composite is 79/100 (Roarable Buy — Very Good Cash & Smart-Money Inflow) in Multi-Sector Companies. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on DLB — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on DLB, but look at what you are paying: 23.1x trailing P/E with 88.1% gross margins. Unless Dolby Laboratories expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
DLB cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on DLB, the market is fixating on short-term headline noise in Multi-Sector Companies and ignoring the balance sheet and cash flow trajectory. At $62.91 (52-wk range $48.26 - $69.95), any beat on forward guidance forces shorts and underweight funds to chase.